A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow.

23.03.2021#6494001

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow.

23.03.2021#6493999

A medic looks at blood samples of a patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine who has come to donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow.

23.03.2021#6493984

Patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow.

23.03.2021#6493976

A medic works with a patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine who has come to donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow.

23.03.2021#6493974

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493970

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493963

A medic takes a pack of frozen plasma donated by patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493961

A medic holds a pack of plasma donated by patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493959

A medic holds packs of frozen plasma donated by patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493955

Patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493951

Antibody-rich plasma donated by a patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine is pictured at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493947

Patients vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493944

A medic works with a patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine who has come to donate antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493940

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493937

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493924

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493922

A patient vaccinated with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine donates antibody-rich plasma at the City Clinical Hospital No 52, in Moscow, Russia. A study on the use of the plasma from vaccinated donors in the treatment of patients with COVID-19 is underway in Moscow .

23.03.2021#6493920